Welcome to INTERNET BULL REPORT   Click to listen highlighted text! Welcome to INTERNET BULL REPORT

African Medicinal Cannabis Entering the Global Market


Wuhan General Group (OTC: $WUHN) announces to have obtained commercial rights for international distribution of medicinal cannabis products.

South Africa could, as one of the countries closest to the Southern Pole, become one of the world leading international-grade medical cannabis exporters.

Farming and agriculture are one of the backbones of South Africa.

With a world-class infrastructure, counter-seasonality to Europe, vast biodiversity and marine resources, and competitive input costs, make the country a major player in the world’s markets.

This means that the market is well set-up for agricultural activities and provide quite good investment opportunities with potentially large profits.



Wuhan General Group and Medigrow Africa aim through the recent agreement to place South Africa on the world map as medicinal cannabis cultivator.

Under the distribution agreement, Wuhan will receive commercial licenses and rights to Medigrow’s portfolio of medical-grade cannabis and hemp products.

“This partnership is the first of many steps going forward with Jeff Robinson and the Wuhan team. We share a common vision and execution strategies that will enable us to build a very profitable global powerhouse.” – Medigrow founder and CEO Willem Jonker


Price Moves

  • Significant news for both parties – and clearly did provide a spike followed by profit-taking.
  • Considering the company’s involvement in both the medicinal cannabis industry and psychedelics sector it seems that it still still hasn’t quite sunk in with investors – which is why we could see some price moves in the future.




Read the full press release here:

Wuhan General Group Signs Distribution Agreement with Medigrow for International Distribution Rights of Medical Cannabis Products

Wednesday, June 10, 2020 8:30 AM EDT

MONTREAL, QC / ACCESSWIRE / June 10, 2020 / WUHAN GENERAL GROUP, INC. (OTC PINK: WUHN) (“Wuhan” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research, is pleased to announce the signing of a distribution agreement with Medigrow Africa (“Medigrow”), an African based medical cannabis company with a formal network of legal African cannabis growers producing international medical-grade cannabis products for global distribution.

Under the distribution agreement, Wuhan will receive commercial licenses and rights to Medigrow’s portfolio of medical-grade cannabis and hemp products. In the terms, Wuhan is granted the rights and will be responsible for marketing, distribution, and sales of certain Medigrow proprietary natural hemp and cannabis-based products.

“We see many strategic business opportunities to expand our relationship with Medigrow and this Agreement is the first of many other significant associations going forward with our partner. The Medigrow portfolio of international-grade medical cannabis products is a very tactical addition to our range of products and it really strengthens our commitment to medical cannabis,” said Jeff Robinson, CEO of Wuhan.

“Our product range has been developed using innovative research and specialized formulations in order to deliver valuable health benefits to the consumer. This partnership will reinforce our brandsDr. AnnaRx™ and Medspresso™ as well as raise awareness on the importance of high premium quality medical cannabis ingredients in our products,” added Dr. Anna, CMO of Wuhan.

Medigrow founder and CEO Willem Jonker said; “This partnership is the first of many steps going forward with Jeff Robinson and the Wuhan team. We share a common vision and execution strategies that will enable us to build a very profitable global powerhouse. “

About Medigrow Africa

Medigrow Africa is a formal network of legal African cannabis growers producing international-grade medical cannabis products for global distribution. Medigrow Africa is the the largest collective of African cannabis businesses and it dominates the African medicinal cannabis industry. Medigrow benefits from lower labor, land, and regulatory costs. Also, Medigrow is in the lower quartile of production costs and the upper quartile of profitability globally.


​Produce European-quality medicinal cannabis with an African cost base.


​Our mission is to give as many people in the world access to medicine from the cannabis plant and to benefit as many Africans as possible through the establishment of a medicinal cannabis industry in Africa.


​For our customers: Medigrow Africa brings exceptional African medicinal cannabis products to the global market by combining global best practice and technical resources with traditional local knowledge and Africa’s favorable climate to grow the highest standard of cannabis.


​Medigrow respects human rights, the rule of law, justice and equality. Therefore, we aim to fully align with the United Nations Agenda 2030 (the Sustainable Development Goals).

​The Global Cannabis market is booming through legalization, declassification, research, entrepreneurship and broader social acceptance. Africa is no different, which is evident in the number of countries that have legalized medicinal cannabis production recently.

​Medigrow envisions Africa as the “centre-court” of future cannabis cultivation. We can see the beginnings of a new legal/formal industry and consequently new means of income, especially in rural areas around Africa. In the longer term, we are convinced that the African Cannabis Industry can help bring steady income to many people that lack work today, assist in building up infrastructure, and blur social stigmas while providing world-class medicinal cannabis to the globe.”

​Our underlying environmental philosophy is continuing to investigate ways to reduce the environmental impact of our operations.

​As part of Medigrow Africa’s intent to maximize the return on every hectare of cannabis, we are particularly mindful of the possible impacts of our operations on the use of natural resources and strive to minimize our impacts through efficient use responsibly and sustainably and through committing ourselves to continuous improvement.

​We strive to comply with all applicable in-country environmental regulations. Furthermore, we are investigating a range of initiatives to preserve ecosystem integrity, protect biodiversity and enhance agricultural sustainability.



Full Disclosure: Jeff Robinson is the CEO, Dr.Anna Morera Leralta the CMO and Luka Marjanovic is the Director of HR and Communications of Wuhan. Please feel free to contact Jeff via email at: jeff@mjmedtech.com.


Luka Marjanovic


Luka holds a Bachelor’s in International Business and a Master’s in International Management. During his undergraduate studies he worked as a research assistant in the field of Big Data; founded his own consulting firm providing services to local SME's in various sectors and invested in the capital markets; as well as working pro-bono providing education and career counselling. Prior to his business education, he studied Biology-and-Biotechnology, and served in the Danish Royal Army as Second Sergeant, leading and managing a group under extreme conditions and pressure. Luka has spent significant time abroad, living and working in seven different countries. When he's not in the office, he's chasing the next gusts windsurfing, carving the mountain snowboarding or out in the forest for a jog.

Click to listen highlighted text!